User:Jennifer Hall: Difference between revisions
| (One intermediate revision by the same user not shown) | |||
| Line 18: | Line 18: | ||
==Education== | ==Education== | ||
University of California Berkeley, Ph.D. | *University of California Berkeley, Ph.D. | ||
Stanford, Postdoctoral Fellowship | *Stanford, Postdoctoral Fellowship | ||
Harvard, Postdoctoral Fellowship | *Harvard, Postdoctoral Fellowship | ||
==Brief Biography== | ==Brief Biography== | ||
Jennifer graduated from the University of California Berkeley in 1995 with a | Jennifer graduated from the University of California Berkeley in 1995 with a Ph.D. in physiology. She completed postdoctoral fellowships at Stanford and Harvard Schools of Medicine and is currently the Director of the Program in Translational Cardiovascular Genomics in the Lillehei Heart Institute at the University of Minnesota. | ||
Dr. Hall is currently the Vice Chair of the Functional Genomics and Translational Biology Council of the American Heart Association. Dr. Hall serves on numerous Committees including the National Heart Lung and Blood Parent Committee, the DNA Framingham Committee, and the Genome Canada Review Board. Dr. Hall serves as an associate editor of JACC and the editor in chief of the Journal of Cardiovascular Translational Research. | Dr. Hall is currently the Vice Chair of the Functional Genomics and Translational Biology Councilhttp://my.americanheart.org/professional/Councils/FGTB-Council-Committee-Involvement-Form_UCM_323121_Form.jsp of the American Heart Association. Dr. Hall serves on numerous Committees including the National Heart Lung and Blood Parent Committee, the DNA Framingham Committee, and the Genome Canada Review Board. Dr. Hall serves as an associate editor of JACC http://content.onlinejacc.org/journal.aspx and the editor in chief of the Journal of Cardiovascular Translational Research http://www.springer.com/medicine/cardiology/journal/12265. | ||
In the last decade, Dr. Hall’s laboratory has been funded from NIH, AHA, JDRF, and the American Diabetes Association. A primary focus of the laboratory during this time has been in understanding the mechanisms governing vascular complications in individuals with diabetes. A focus in the Hall lab has been to define the role of heparan sulfate fine structure on vascular structure and function. A second focus of the Hall lab is to identify genes and signaling pathways that are modified in response to reversal of heart failure or left ventricular remodeling. | In the last decade, Dr. Hall’s laboratory has been funded from NIH, AHA, JDRF, and the American Diabetes Association. A primary focus of the laboratory during this time has been in understanding the mechanisms governing vascular complications in individuals with diabetes. A focus in the Hall lab has been to define the role of heparan sulfate fine structure on vascular structure and function. A second focus of the Hall lab is to identify genes and signaling pathways that are modified in response to reversal of heart failure or left ventricular remodeling. | ||
As the Director of the Program in Translational Cardiovascular Genomics, Dr. Hall has helped to establish a research program that includes genomics in the area of heart failure at the University of Minnesota. Over the past decade, Dr. Hall has worked with clinician/scientists and surgeons to train fellows and students, increase the quality of translational research, and develop new guidelines and innovative techniques to promote quality patient care at the University of Minnesota. In the last decade, multiple manuscripts have been led by fellows in this Program combining both clinical and genomic research. The continued mission of this Program is to promote a high quality training program for students, fellows, and residents in cross-disciplinary translational research. | As the Director of the Program in Translational Cardiovascular Genomics, Dr. Hall has helped to establish a research program that includes genomics in the area of heart failure at the University of Minnesota. Over the past decade, Dr. Hall has worked with clinician/scientists and surgeons to train fellows and students, increase the quality of translational research, and develop new guidelines and innovative techniques to promote quality patient care at the University of Minnesota. In the last decade, multiple manuscripts have been led by fellows in this Program combining both clinical and genomic research. The continued mission of this Program is to promote a high quality training program for students, fellows, and residents in cross-disciplinary translational research. | ||
Latest revision as of 20:36, 14 October 2013
Jennifer L. Hall, Ph.D., FACC, FAHA
Jennifer L. Hall, Ph.D., FACC, FAHA
Associate Editor in Chief
Contact:
Email: jlhall@umn.edu
Current Position
- Associate Editor in Chief
Dilated Cardiomyopathy, Pathophysiology, Genetics
Professional Background
- Director, Program in Translational Genomics, University of Minnesota, http://www.med.umn.edu/lhi/research/LHI_Genomics/home.html
- Associate Professor, Department of Medicine, University of Minnesota, http://www.redhotsoiree.umn.edu/research/JHall_lab/home.html
- Visiting Professor, University of Virginia
Education
- University of California Berkeley, Ph.D.
- Stanford, Postdoctoral Fellowship
- Harvard, Postdoctoral Fellowship
Brief Biography
Jennifer graduated from the University of California Berkeley in 1995 with a Ph.D. in physiology. She completed postdoctoral fellowships at Stanford and Harvard Schools of Medicine and is currently the Director of the Program in Translational Cardiovascular Genomics in the Lillehei Heart Institute at the University of Minnesota. Dr. Hall is currently the Vice Chair of the Functional Genomics and Translational Biology Councilhttp://my.americanheart.org/professional/Councils/FGTB-Council-Committee-Involvement-Form_UCM_323121_Form.jsp of the American Heart Association. Dr. Hall serves on numerous Committees including the National Heart Lung and Blood Parent Committee, the DNA Framingham Committee, and the Genome Canada Review Board. Dr. Hall serves as an associate editor of JACC http://content.onlinejacc.org/journal.aspx and the editor in chief of the Journal of Cardiovascular Translational Research http://www.springer.com/medicine/cardiology/journal/12265.
In the last decade, Dr. Hall’s laboratory has been funded from NIH, AHA, JDRF, and the American Diabetes Association. A primary focus of the laboratory during this time has been in understanding the mechanisms governing vascular complications in individuals with diabetes. A focus in the Hall lab has been to define the role of heparan sulfate fine structure on vascular structure and function. A second focus of the Hall lab is to identify genes and signaling pathways that are modified in response to reversal of heart failure or left ventricular remodeling.
As the Director of the Program in Translational Cardiovascular Genomics, Dr. Hall has helped to establish a research program that includes genomics in the area of heart failure at the University of Minnesota. Over the past decade, Dr. Hall has worked with clinician/scientists and surgeons to train fellows and students, increase the quality of translational research, and develop new guidelines and innovative techniques to promote quality patient care at the University of Minnesota. In the last decade, multiple manuscripts have been led by fellows in this Program combining both clinical and genomic research. The continued mission of this Program is to promote a high quality training program for students, fellows, and residents in cross-disciplinary translational research.